Join
Live feed
·
INSIDERFilingvia Quantisnow
Castle Biosciences Inc. logo

Chief Operating Officer Oelschlager Kristen M sold $209,650 worth of shares (8,586 units at $24.42) as part of a pre-agreed trading plan, decreasing direct ownership by 28% to 21,874 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CSTL· Castle Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CSTL (Castle Biosciences Inc.) and more on Quantisnow.